Tarsus Pharmaceuticals (TARS) EPS (Basic) (2019 - 2026)
Tarsus Pharmaceuticals (TARS) recorded quarterly EPS (Basic) of -$0.16 in Q1 2026, up 15.79% quarter-over-quarter from -$0.19 in Q4 2025, and up 75.0% on a YoY basis from -$0.09 in Q1 2025.
Tarsus Pharmaceuticals (TARS) EPS (Basic) (2019 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$0.16 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 75.0% year-over-year to -$0.16; the TTM figure through Mar 2026 stood at -$1.13 (up 58.46% YoY), while the FY2025 annual figure was -$1.59, up 48.21% from the prior year.
- EPS (Basic) was -$0.16 for Q1 2026 at Tarsus Pharmaceuticals, up from -$0.19 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.16 in Q1 2026 to a low of -$1.28 in Q3 2023.
- Historically, EPS (Basic) has averaged -$0.71 across 5 years, with a median of -$0.64 in 2025.
- The sharpest annual moves came in 2023 and 2026: EPS (Basic) tumbled 387.5% in 2023, then jumped 75.0% in 2026.
- A 5-year view of EPS (Basic) shows it stood at -$0.49 in 2022, then plunged by 159.18% to -$1.27 in 2023, then soared by 53.54% to -$0.59 in 2024, then soared by 67.8% to -$0.19 in 2025, then rose by 15.79% to -$0.16 in 2026.
- The last three EPS (Basic) figures came in at -$0.16 (Q1 2026), -$0.19 (Q4 2025), and -$0.3 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Tarsus Pharmaceuticals | 2.71 Bn | 2.61 Bn | 152.66 Mn | -0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.16 |
| Dec 31, 2025 | -0.19 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.48 |
| Mar 31, 2025 | -0.64 |
| Dec 31, 2024 | -0.59 |
| Sep 30, 2024 | -0.61 |
| Jun 30, 2024 | -0.88 |
| Mar 31, 2024 | -1.01 |
| Dec 31, 2023 | -1.27 |
| Sep 30, 2023 | -1.28 |
| Jun 30, 2023 | -1.17 |
| Mar 31, 2023 | -0.88 |
| Dec 31, 2022 | -0.49 |
| Sep 30, 2022 | -0.84 |
| Jun 30, 2022 | -0.24 |
| Mar 31, 2022 | -0.98 |
| Dec 31, 2021 | -0.72 |
| Sep 30, 2021 | -0.76 |
| Jun 30, 2021 | 0.31 |